Brianne Kaiser

899 citations
4 papers · 611 · 1 hit paper · h-index 4

Impact in

  • Oncology top 10%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Inflammatory Biomarkers in Disease Prognosis 1
    • Lung Cancer Research Studies 1
    • Multiple Myeloma Research and Treatments 1

Brianne Kaiser

4 papers receiving 602 citations

Brianne Kaiser's Hit Papers

The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer 2012 · 355 citations
3550+4+9Years since publication100200300

Peers

Brianne Kaiser
Comparison fields: 5 of 64
  • Oncology 200
  • Cancer Research 79
  • Endocrinology, Diabetes and Metabolism 87
  • Molecular Biology 346
  • Pathology and Forensic Medicine 81
Replace Greg Friberg with:
Greg Friberg United States
Suresh Anaganti Italy
Karl Hsu United States
Lorenza Pistola Italy
Lorina Dudkin United States
Takehiro Wakasugi Japan
Hyesil Seol South Korea
James A. Onori United States
Kanenori Endo Japan
Alicia Morresi‐Hauf Germany
Brianne Kaiser relative to Greg Friberg United States Greg Friberg's profile →
Citations per field
00.5×
Greg Friberg · 1×
Citations per year

Countries citing papers authored by Brianne Kaiser

Since Specialization
Citations

This map shows the geographic impact of Brianne Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brianne Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brianne Kaiser more than expected).

Fields of papers citing papers by Brianne Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brianne Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brianne Kaiser. The network helps show where Brianne Kaiser may publish in the future.

Co-authors

The 25 scholars most cited alongside Brianne Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brianne Kaiser Line = papers co-authored together Brianne Kaiser links everyone, so they are left out of the graph.

All Works

4 of 4 papers shown
#Work
1
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
Hit paper breakdown →
2012355
2 2009238
3 20139
4 20189

About Brianne Kaiser

Brianne Kaiser is a scholar working on Oncology, Hematology, Endocrinology, Diabetes and Metabolism, Infectious Diseases and Organic Chemistry, having authored 4 papers that have together received 611 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (1 paper), Multiple Myeloma Research and Treatments (1 paper), Lung Cancer Research Studies (1 paper) and Growth Hormone and Insulin-like Growth Factors (1 paper). The work is most often cited by research in Oncology (200 citations), Cancer Research (79 citations), Endocrinology, Diabetes and Metabolism (87 citations), Molecular Biology (346 citations) and Pathology and Forensic Medicine (81 citations). Brianne Kaiser has collaborated with scholars based in United States. Frequent co-authors include Amita Patnaik, Anthony W. Tolcher, Kyriakos P. Papadopoulos, Lon Smith, Toshio Shimizu, Muralidhar Beeram, G. Mangold, Leslie Smetzer, Cathy Alvarez and Michael J. Wick. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Ovarian Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact